Tommy Cannon shares prostate cancer update with fans and urges men to get tested - The Independent
Tommy Cannon shares prostate cancer update with fans and urges men to get tested The Independent
Prostate Cancer News
‘I’ve been living under a shadow for 13 years’: life with prostate cancer - The Guardian
‘I’ve been living under a shadow for 13 years’: life with prostate cancer The Guardian
‘Conqueror’: Black Cleveland minister shares prostate cancer battle - Cleveland.com
‘Conqueror’: Black Cleveland minister shares prostate cancer battle Cleveland.com
Treating Biochemical Recurrence in Oligometastatic Prostate Cancer - CancerNetwork
Treating Biochemical Recurrence in Oligometastatic Prostate Cancer CancerNetwork
Prostate cancer screening just as good as routine breast cancer checks, study says - so will change happen? - Sky News
Prostate cancer screening just as good as routine breast cancer checks, study says - so will change happen? Sky News
PSMA-PET Cuts Need for Biopsy in Suspected Prostate Cancer - MedPage Today
PSMA-PET Cuts Need for Biopsy in Suspected Prostate Cancer MedPage Today
EAU 2026: Update on High-risk Non-metastatic Hormone-sensitive Prostate Cancer - UroToday
EAU 2026: Update on High-risk Non-metastatic Hormone-sensitive Prostate Cancer UroToday
Trial Supports MRI-guided TULSA Procedure for Prostate Cancer Safety - Cure Today
Trial Supports MRI-guided TULSA Procedure for Prostate Cancer Safety Cure Today
Alessa Therapeutics Announces Positive Preliminary Safety and Efficacy Data from Enolen Phase 1 Trial - BioSpace
Alessa Therapeutics Announces Positive Preliminary Safety and Efficacy Data from Enolen Phase 1 Trial BioSpace
Adoption and Practice Variability of Prostate Stereotactic Body Radiotherapy (SBRT) in Latin America: The Role of Continuous Education in Advancing Quality and Standardization - Cureus
Adoption and Practice Variability of Prostate Stereotactic Body Radiotherapy (SBRT) in Latin America: The Role of Continuous Education in Advancing Quality and Standardization Cureus
Prostate Radiotherapy in Metastatic Prostate Cancer: New Evidence by Disease Burden - Oncodaily
Prostate Radiotherapy in Metastatic Prostate Cancer: New Evidence by Disease Burden Oncodaily
Prostate cancer screening achieves mammography-like benefits, new research suggests - Oncology Central
Prostate cancer screening achieves mammography-like benefits, new research suggests Oncology Central
Risk-Adapted Prostate Screening Shows Comparable Performance to Mammography - Inside Precision Medicine
Risk-Adapted Prostate Screening Shows Comparable Performance to Mammography Inside Precision Medicine
Why Bone Health is Crucial in Prostate Cancer Treatment(1) - Targeted Oncology
Why Bone Health is Crucial in Prostate Cancer Treatment(1) Targeted Oncology
Personalizing Care Improves Outcomes in Metastatic Prostate Cancer - Cure Today
Personalizing Care Improves Outcomes in Metastatic Prostate Cancer Cure Today
Advances in prostate cancer detection may lower deaths, according to Yale study - News12 | Connecticut
Advances in prostate cancer detection may lower deaths, according to Yale study News12 | Connecticut
Six biotech companies advancing the next generation of prostate cancer therapies - Labiotech.eu
Six biotech companies advancing the next generation of prostate cancer therapies Labiotech.eu
MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy - Medscape
MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy Medscape
EAU 2026: Presentation of APCCC 2024/2025 Results on Synchronous High-volume mHSPC & Voting - UroToday
EAU 2026: Presentation of APCCC 2024/2025 Results on Synchronous High-volume mHSPC & Voting UroToday
PSMA PET Applications in Prostate Cancer Management - Targeted Oncology
PSMA PET Applications in Prostate Cancer Management Targeted Oncology
Enolen Displays 84% Reduction in Tumor Volume of Localized Prostate Cancer - CancerNetwork
Enolen Displays 84% Reduction in Tumor Volume of Localized Prostate Cancer CancerNetwork
Raul Tirinescu Explores the Timing of Lutetium-177 PSMA Therapy in Prostate Cancer Treatment - Oncodaily
Raul Tirinescu Explores the Timing of Lutetium-177 PSMA Therapy in Prostate Cancer Treatment Oncodaily
Longitudinal Analysis of Patient-Reported Outcomes in the PSMAddition Trial - Michael Morris - UroToday
Longitudinal Analysis of Patient-Reported Outcomes in the PSMAddition Trial - Michael Morris UroToday
EAU 2026: State of the Art Lecture: PARP Inhibitors in mHSPC and mCRPC - UroToday
EAU 2026: State of the Art Lecture: PARP Inhibitors in mHSPC and mCRPC UroToday
Salvage Radiotherapy Intensification Tested in Men with High-Risk Biochemical Recurrence - Edwin Posadas - UroToday
Salvage Radiotherapy Intensification Tested in Men with High-Risk Biochemical Recurrence - Edwin Posadas UroToday
Finding Your Seat at the Table: Advice for Women Forging Careers in Medicine - Fatima Karzai - UroToday
Finding Your Seat at the Table: Advice for Women Forging Careers in Medicine - Fatima Karzai UroToday
Neha Vapiwala, MD, on Highlights in Prostate Cancer From ASCO GU 2026 - The ASCO Post
Neha Vapiwala, MD, on Highlights in Prostate Cancer From ASCO GU 2026 The ASCO Post
EAU: Experts highlight imaging advances in prostate cancer screening - AuntMinnie
EAU: Experts highlight imaging advances in prostate cancer screening AuntMinnie
Singleton, Stack Bill Expanding Prostate Cancer Screening Coverage Advances - New Jersey Senate Democrats
Singleton, Stack Bill Expanding Prostate Cancer Screening Coverage Advances New Jersey Senate Democrats
Prostate cancer survivor shares information, support with men newly diagnosed - KFYR-TV
Prostate cancer survivor shares information, support with men newly diagnosed KFYR-TV
Denying prostate cancer screening 'no longer rational' - pharmaphorum
Denying prostate cancer screening 'no longer rational' pharmaphorum
Astellas and Vir Biotechnology Form $1.7B Collaboration to Advance Prostate Cancer Therapy - The Healthcare Technology Report.
Astellas and Vir Biotechnology Form $1.7B Collaboration to Advance Prostate Cancer Therapy The Healthcare Technology Report.
EAU 2026: Patient Preferences in Prostate Cancer Treatment Decisions - European Medical Journal
EAU 2026: Patient Preferences in Prostate Cancer Treatment Decisions European Medical Journal
EAU 2026: How to Read a Genetic Report for Clinical Practice? - UroToday
EAU 2026: How to Read a Genetic Report for Clinical Practice? UroToday
EAU 2026: DISSECTION 2.0 – Extended Pelvic Lymph Node Dissection versus No Pelvic Lymph Node Dissection at Radical Prostatectomy in PSMA PET Negative Staged Men: A Multicenter, Randomized Phase III Trial - UroToday
EAU 2026: DISSECTION 2.0 – Extended Pelvic Lymph Node Dissection versus No Pelvic Lymph Node Dissection at Radical Prostatectomy in PSMA PET Negative Staged Men: A Multicenter, Randomized Phase III Trial UroToday
How MRD Could Fast-Track Cancer Breakthroughs - Targeted Oncology
How MRD Could Fast-Track Cancer Breakthroughs Targeted Oncology
EAU 2026: Who Benefits from Intensification with Docetaxel? - UroToday
EAU 2026: Who Benefits from Intensification with Docetaxel? UroToday
Keeping Bone Health Top of Mind in Androgen Deprivation Therapy - Targeted Oncology
Keeping Bone Health Top of Mind in Androgen Deprivation Therapy Targeted Oncology
Free prostate cancer screenings set for March 18 in Newnan - The Newnan Times-Herald
Free prostate cancer screenings set for March 18 in Newnan The Newnan Times-Herald
Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal - Morningstar
Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal Morningstar